Noel W Clarke

Noel W Clarke

UNVERIFIED PROFILE

Are you Noel W Clarke?   Register this Author

Register author
Noel W Clarke

Noel W Clarke

Publications by authors named "Noel W Clarke"

Are you Noel W Clarke?   Register this Author

100Publications

2103Reads

37Profile Views

Prostate radiotherapy in newly diagnosed metastatic prostate cancer.

Curr Opin Urol 2019 Nov;29(6):620-628

Genito-Urinary Cancer Research Group and the FASTMAN Prostate Cancer Centre for Excellence, Division of Cancer Sciences, Manchester Cancer Research Centre, The University of Manchester, Manchester.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000675DOI Listing
November 2019

Multiple primary malignancies associated with a germline SMARCB1 pathogenic variant.

Fam Cancer 2019 10;18(4):445-449

Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals Foundation Trust, Manchester, M13 9WL, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-019-00138-4DOI Listing
October 2019

Radiotherapy for metastatic prostate cancer-Authors' reply.

Lancet 2019 09;394(10201):830

Medical Research Council Clinical Trials Unit at University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)31829-XDOI Listing
September 2019

Imputation of missing prostate cancer stage in English cancer registry data based on clinical assumptions.

Cancer Epidemiol 2019 02 18;58:44-51. Epub 2018 Nov 18.

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, England, United Kingdom; Clinical Effectiveness Unit, The Royal College of Surgeons of England, 35-43 Lincoln's Inn Fields, London, WC2A 3PE, England, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2018.11.003DOI Listing
February 2019

Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate Cancer.

Eur Urol Oncol 2019 Feb 5;2(1):1-11. Epub 2018 Sep 5.

Belfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK; Prostate Oncobiology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2018.08.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472613PMC
February 2019

Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer.

BJU Int 2019 01 13;123(1):65-73. Epub 2018 Jun 13.

Genito-Urinary Cancer Research Group, Division of Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14400DOI Listing
January 2019

Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer.

Cell Rep 2018 12;25(12):3504-3518.e6

Prostate Oncobiology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park SK10 4TG, UK; Belfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park SK10 4TG, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22111247183184
Publisher Site
http://dx.doi.org/10.1016/j.celrep.2018.11.069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315111PMC
December 2018

Mapping Hypoxia in Renal Carcinoma with Oxygen-enhanced MRI: Comparison with Intrinsic Susceptibility MRI and Pathology.

Radiology 2018 09 5;288(3):739-747. Epub 2018 Jun 5.

From the Centre for Imaging Sciences (R.A.L., J.H.N., Y.W., S.C., K.F.H., H.L., D.J.M., G.J.M.P., J.C.W.) and Division of Cancer Sciences (J.I., C.M.L.W., N.W.C., J.P.B.O.), University of Manchester, Manchester, England; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, England (Y.J., J.K.R.B., S.P.R.); Department of Pathology, Central Manchester University Hospitals NHS Foundation Trust, Manchester, England (G.N.B.); Department of Histology, CRUK Manchester Institute, Manchester, England (G.A.); Tumour Biology Team, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England (A.R.R.); Department of Urology, Salford Royal Hospitals NHS Foundation Trust, Salford, England (S.M., N.W.C.); Bioxydyn Ltd, Manchester, England (G.J.M.P., J.C.W.); and Department of Radiology, The Christie NHS Foundation Trust, Manchester, England (J.P.B.O.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2018171531DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122194PMC
September 2018

Treatment-related toxicity in men who received Intensity-modulated versus 3D-conformal radiotherapy after radical prostatectomy: A national population-based study.

Radiother Oncol 2018 08 14;128(2):357-363. Epub 2018 May 14.

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom; Department of Radiotherapy, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2018.04.032DOI Listing
August 2018

Magnetic Resonance Imaging and Detection of Metastases in Prostate Cancer: Learning Lessons from History.

Eur Urol 2018 01 8;73(1):92-93. Epub 2017 Jun 8.

The Christie and Salford Royal Hospitals, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.05.052DOI Listing
January 2018

National Population-Based Study Comparing Treatment-Related Toxicity in Men Who Received Intensity Modulated Versus 3-Dimensional Conformal Radical Radiation Therapy for Prostate Cancer.

Int J Radiat Oncol Biol Phys 2017 12 1;99(5):1253-1260. Epub 2017 Sep 1.

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom; Department of Radiotherapy, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.07.040DOI Listing
December 2017

Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer.

J Clin Oncol 2017 09 10;35(27):3097-3104. Epub 2017 Aug 10.

Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana-Farber Cancer Institute, Boston, MA; Marc Buyse, International Drug Development Institute; Bertrand Tombal, Université Catholique de Louvain, Louvain-la-Neuve; Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Susan Halabi, Duke University Medical Center, Durham, NC; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; Oliver Sartor, Tulane Medical School, New Orleans, LA; Howard Soule, Prostate Cancer Foundation, Santa Monica; Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles, CA; Noel W. Clarke, The Christie NHS Foundation Trust, Manchester; Matthew R. Sydes, University College London, London, United Kingdom; James J. Dignam, University of Chicago, Chicago, IL; Karim Fizazi, Institut Gustave-Roussy, Villejuif, France; Wendy R. Paruleker, Canadian Cancer Trials Group, Kingston, Ontario, Canada; and Scott G. Williams, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.9987DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652387PMC
September 2017

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

N Engl J Med 2017 07 3;377(4):338-351. Epub 2017 Jun 3.

From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom; and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1702900DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533216PMC
July 2017

Identification and evaluation of clinically significant prostate cancer: a step towards personalized diagnosis.

Curr Opin Urol 2017 May;27(3):217-224

aProstate Oncobiology bCancer Research UK Manchester Institute cBelfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, University of Manchester dDepartment of Surgery, The Christie NHS Foundation Trust, Manchester eDepartment of Urology, Salford NHS Foundation Trust, Salford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000385DOI Listing
May 2017

Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial.

J Clin Oncol 2017 May 13;35(14):1530-1541. Epub 2017 Mar 13.

Malcolm D. Mason, Cardiff University School of Medicine, Velindre Hospital; Jim Barber, Velindre Cancer Centre, Cardiff; Noel W. Clarke, The Christie and Salford Royal NHS Foundation Trusts; John Logue, Christie Hospital, Manchester; Nicholas D. James, Institute of Cancer and Genomic Sciences; Emilio Porfiri, The Medical School, University of Birmingham; Nicholas D. James, Queen Elizabeth Hospital; Emilio Porfiri, University Hospitals Birmingham NHS Foundation Trust, Birmingham; David P. Dearnaley, Gerhardt Attard, and Christopher C. Parker, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust; Melissa R. Spears, Alastair W.S. Ritchie, Francesca Schiavone, David Matheson, Robin Millman, Clare Gilson, Mahesh K.B. Parmar, and Matthew R. Sydes, MRC Clinical Trials Unit at UCL, London; William Cross, Leeds Teaching Hospitals NHS Trust, Leeds; Rob J. Jones and J. Martin Russell, University of Glasgow; Rob J. Jones and Jan Wallace, Beatson West of Scotland Cancer Centre, Glasgow; Azman Ibrahim, The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral; Anna Lydon, Torbay District Hospital, Torquay; Ashok D. Nikapota, Sussex Cancer Centre, Brighton; Ashok D. Nikapota, Worthing Hospital, Worthing; Joe M. O'Sullivan, Centre for Cancer Research and Cell Biology, Queen's University, Belfast; Andrew Protheroe, Churchill Hospital, Oxford; Narayanan Nair Srihari, Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury; David Tsang, Southend Hospital, Southend-on-Sea; David Tsang, Basildon Hospital, Basildon; John Wagstaff, The South West Wales Cancer Institute; John Wagstaff, Swansea University College of Medicine, Swansea; Catherine Walmsley, Royal Preston Hospital, Preston, United Kingdom; George N. Thalmann, University Hospital; Estelle Cassoly, SAKK Coordinating Center, Berne; and Cyrill A. Rentsch, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.0677DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455701PMC
May 2017

Infrared spectral histopathology using haematoxylin and eosin (H&E) stained glass slides: a major step forward towards clinical translation.

Analyst 2017 Apr;142(8):1258-1268

Manchester Institute of Biotechnology, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.

View Article

Download full-text PDF

Source
http://xlink.rsc.org/?DOI=C6AN02224C
Publisher Site
http://dx.doi.org/10.1039/c6an02224cDOI Listing
April 2017

STAMPEDE trial and patients with non-metastatic prostate cancer - Authors' reply.

Lancet 2016 Jul;388(10041):235-6

Medical Research Council, Clinical Trials Unit, University College London, London WC2B 6NH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(16)31041-8DOI Listing
July 2016

High-throughput quantum cascade laser (QCL) spectral histopathology: a practical approach towards clinical translation.

Faraday Discuss 2016 06;187:135-54

Manchester Institute of Biotechnology, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c5fd00176eDOI Listing
June 2016

Is it safe to insert a testicular prosthesis at the time of radical orchidectomy for testis cancer: an audit of 904 men undergoing radical orchidectomy.

BJU Int 2016 Feb 25;117(2):249-52. Epub 2015 May 25.

Department of Urology, The Christie NHS Foundation Trust, University Hospital of South Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12920DOI Listing
February 2016

External urethral sphincter electromyography in asymptomatic women and the influence of the menstrual cycle.

BJU Int 2015 Sep 4;116(3):423-31. Epub 2015 May 4.

Department of Urology, Salford Royal NHS Foundation Trust, Salford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.13042DOI Listing
September 2015

Quantification of skeletal metastases in castrate-resistant prostate cancer predicts progression-free and overall survival.

BJU Int 2014 Dec 27;114(6b):E70-E73. Epub 2014 Jul 27.

Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bju.12717
Publisher Site
http://dx.doi.org/10.1111/bju.12717DOI Listing
December 2014

Assessing the challenges of Fourier transform infrared spectroscopic analysis of blood serum.

J Biophotonics 2014 Apr 31;7(3-4):180-8. Epub 2014 Jan 31.

Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK; Genito Urinary Cancer Research Group, Institute of Cancer Sciences, Paterson Building, The University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, M20 4BX, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbio.201300167DOI Listing
April 2014

Balancing toxicity and efficacy: learning from trials and treatment using antiresorptive therapy in prostate cancer.

Authors:
Noel W Clarke

Eur Urol 2014 Feb 26;65(2):287-8. Epub 2013 Jul 26.

The Christie and Salford Royal Hospitals, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2013.07.026DOI Listing
February 2014

Whole organ cross-section chemical imaging using label-free mega-mosaic FTIR microscopy.

Analyst 2013 Dec 9;138(23):7066-9. Epub 2013 Oct 9.

Manchester Institute of Biotechnology, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c3an01674aDOI Listing
December 2013

Coming up for air: follow-up and risk stratification after negative prostate cancer screening.

Authors:
Noel W Clarke

Eur Urol 2013 Apr 13;63(4):634-5; discussion 635-6. Epub 2012 Aug 13.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2012.08.007DOI Listing
April 2013

FTIR microspectroscopy of selected rare diverse sub-variants of carcinoma of the urinary bladder.

J Biophotonics 2013 Jan 2;6(1):73-87. Epub 2012 Nov 2.

Manchester Institute of Biotechnology, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbio.201200126DOI Listing
January 2013

Landmarks in non-hormonal pharmacological therapies for castration-resistant prostate cancer.

Authors:
Noel W Clarke

BJU Int 2012 Oct;110 Suppl 1:14-22

The Christie and Salford Royal Hospitals, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11430.xDOI Listing
October 2012

FTIR microscopy of biological cells and tissue: data analysis using resonant Mie scattering (RMieS) EMSC algorithm.

Analyst 2012 Mar 9;137(6):1370-7. Epub 2012 Feb 9.

Manchester Interdisciplinary Biocentre, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c2an16088aDOI Listing
March 2012

Is population screening for prostate cancer good or bad?

Authors:
Noel W Clarke

Eur Urol 2011 Mar 1;59(3):363-4. Epub 2010 Dec 1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2010.11.027DOI Listing
March 2011

Integrating surgery with targeted therapies for renal cell carcinoma: maximizing benefits, minimizing risk.

Authors:
Noel W Clarke

Eur Urol 2010 Dec 26;58(6):829-30. Epub 2010 Sep 26.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2010.09.027DOI Listing
December 2010

SR-FTIR spectroscopy of renal epithelial carcinoma side population cells displaying stem cell-like characteristics.

Analyst 2010 Dec 27;135(12):3133-41. Epub 2010 Oct 27.

Manchester Interdisciplinary Biocentre, University of Manchester, 131 Princess Street, Manchester, UK M1 7DN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c0an00574fDOI Listing
December 2010

Differential complication rates following radical cystectomy in the irradiated and nonirradiated pelvis.

Eur Urol 2010 Jun 10;57(6):1058-63. Epub 2009 Dec 10.

The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2009.12.002DOI Listing
June 2010

Open to debate. The motion: GnRH antagonists are the new way forward in hormonal therapy.

Eur Urol 2010 Mar 2;57(3):534-7. Epub 2009 Dec 2.

Department of Urological Oncology, Christie and Salford Royal Hospitals, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2009.11.040DOI Listing
March 2010

Imaging angiogenesis of genitourinary tumors.

Nat Rev Urol 2010 Feb 19;7(2):69-82. Epub 2010 Jan 19.

Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2009.262DOI Listing
February 2010

Hoechst 33342 side population identification is a conserved and unified mechanism in urological cancers.

Stem Cells Dev 2009 Dec;18(10):1515-22

Genito-Urinary Cancer Research Group, School of Cancer and Imaging Sciences, Paterson Institute for Cancer Research, Manchester M20 4BX, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/scd.2008.0302DOI Listing
December 2009

A contemporary standard for morbidity and outcome after radical cystectomy.

BJU Int 2009 Sep 17;104(5):628-32. Epub 2009 Apr 17.

Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2009.08506.xDOI Listing
September 2009

Male adnexal tumour of wolffian origin: the first report of metastatic disease.

Scand J Urol Nephrol 2009 ;43(3):253-6

Department of Urology, Salford Royal Hospitals NHS Foundation Trust, Salford, Greater Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00365590802519412DOI Listing
June 2009

Reflection contributions to the dispersion artefact in FTIR spectra of single biological cells.

Analyst 2009 Jun 9;134(6):1171-5. Epub 2009 Apr 9.

School of Chemical Engineering and Analytical Science, Manchester Interdisciplinary Biocentre, The University of Manchester, 131 Princess Street, Manchester, UK M1 7DN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/b821349fDOI Listing
June 2009

Cd133: a marker of transit amplification rather than stem cell phenotype in the prostate?

BJU Int 2009 Apr 5;103(7):856-8. Epub 2008 Dec 5.

Genito-Urinary Cancer Research Group, University of Manchester Paterson Institute for Cancer Research, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2008.08250.xDOI Listing
April 2009

Spectral discrimination of live prostate and bladder cancer cell lines using Raman optical tweezers.

J Biomed Opt 2008 Nov-Dec;13(6):064004

University of Manchester, School of Chemical Engineering and Analytical Science, Manchester Interdisciplinary Biocentre, 131 Princess Street, Manchester, Manchester M1 7DN, United Kingdom.

View Article

Download full-text PDF

Source
http://biomedicaloptics.spiedigitallibrary.org/article.aspx?
Publisher Site
http://dx.doi.org/10.1117/1.2999609DOI Listing
March 2009

Classification of fixed urological cells using Raman tweezers.

J Biophotonics 2009 Feb;2(1-2):47-69

School of Chemical Engineering and Analytical Science, Manchester Interdisciplinary Biocentre, University of Manchester, 131 Princess Street, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbio.200810061DOI Listing
February 2009

Investigating FTIR based histopathology for the diagnosis of prostate cancer.

J Biophotonics 2009 Feb;2(1-2):104-13

Manchester Interdisciplinary Biocentre, Centre for Instrumentation and Analytical Science, School of Chemical Engineering and Analytical Science, The University of Manchester, 131 Princess Street, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbio.200810062DOI Listing
February 2009

Molecular mechanisms of metastasis in prostate cancer.

Asian J Androl 2009 Jan 1;11(1):57-67. Epub 2008 Dec 1.

Genito-Urinary Cancer Research Group, School of Cancer and Imaging Sciences, Paterson Institute for Cancer Research, Christie Hospital, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/aja.2008.29DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735202PMC
January 2009

Bisphosphonates in hormone-refractory prostate cancer: do we have a toxicity problem?

Authors:
Noel W Clarke

Eur Urol 2008 Nov 3;54(5):974-5. Epub 2008 Aug 3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2008.07.061DOI Listing
November 2008

Measurement of elastic properties of prostate cancer cells using AFM.

Analyst 2008 Nov 25;133(11):1498-500. Epub 2008 Jul 25.

School of Chemical Engineering and Analytical Science, Manchester Interdisciplinary Biocentre, The University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/b803355bDOI Listing
November 2008

Aetiology, diagnosis and management of urothelial tumours of the renal pelvis and ureter.

BJU Int 2008 Nov;102(9 Pt B):1302-6

Department of Urology, Christie Hospital NHS Foundation Trust, Manchester, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1464-410X.2008.07974.x
Publisher Site
http://dx.doi.org/10.1111/j.1464-410X.2008.07974.xDOI Listing
November 2008

Characterization of the Hoechst 33342 side population from normal and malignant human renal epithelial cells.

Am J Physiol Renal Physiol 2008 Sep 9;295(3):F680-7. Epub 2008 Jul 9.

Genito-Urinary Cancer Research Group, School of Cancer and Imaging Sciences, Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajprenal.90286.2008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2536866PMC
September 2008

Editorial comment on: noninvasive detection of testicular carcinoma in situ in semen using OCT3/4.

Authors:
Noel W Clarke

Eur Urol 2008 Jul 1;54(1):159-60. Epub 2007 Nov 1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2007.10.044DOI Listing
July 2008

Late tissue effects following radiotherapy and neoadjuvant hormone therapy of the prostate measured with quantitative magnetic resonance imaging.

Radiother Oncol 2008 Jul 14;88(1):127-34. Epub 2008 Mar 14.

Imaging Science and Biomedical Engineering, University of Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2008.02.018DOI Listing
July 2008

Discrimination of prostate cancer cells and non-malignant cells using secondary ion mass spectrometry.

Analyst 2008 Feb 30;133(2):175-9. Epub 2007 Nov 30.

Manchester Interdisciplinary Biocentre, Centre for Instrumentation and Analytical Science, School of Chemical Engineering and Analytical Science, The University of Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/b712853cDOI Listing
February 2008

Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations.

Prostate 2007 Sep;67(13):1384-96

ProMPT Genito-Urinary Cancer Research Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.20620DOI Listing
September 2007

Direct evidence of lipid translocation between adipocytes and prostate cancer cells with imaging FTIR microspectroscopy.

J Lipid Res 2007 Aug 11;48(8):1846-56. Epub 2007 May 11.

ProMPT Genito Urinary Cancer Research Group, Paterson Institute for Cancer Research, The University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.M700131-JLR200DOI Listing
August 2007

Optical artefacts in transflection mode FTIR microspectroscopic images of single cells on a biological support: the effect of back-scattering into collection optics.

Analyst 2007 Aug 12;132(8):750-5. Epub 2007 Jun 12.

School of Chemistry, University of Manchester, P.O. Box 88, Manchester, UK M60 1QD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/b702064cDOI Listing
August 2007

Discrimination of prostate cancer cells by reflection mode FTIR photoacoustic spectroscopy.

Analyst 2007 Apr 8;132(4):292-5. Epub 2007 Mar 8.

School of Chemical Engineering and Analytical Science, Manchester Interdisciplinary Biocentre, University of Manchester, 131 Princess Street, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/b618618aDOI Listing
April 2007

The origin of the bone scan as a tumour marker in prostate cancer.

Authors:
Noel W Clarke

Eur Urol 2006 Nov 7;50(5):873-8. Epub 2006 Sep 7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2006.08.033DOI Listing
November 2006

A correlation of FTIR spectra derived from prostate cancer biopsies with gleason grade and tumour stage.

Eur Urol 2006 Oct 31;50(4):750-60; discussion 760-1. Epub 2006 Mar 31.

School of Chemical Engineering and Analytical Science, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2006.03.031DOI Listing
October 2006

Management of the spectrum of hormone refractory prostate cancer.

Authors:
Noel W Clarke

Eur Urol 2006 Sep 2;50(3):428-38; discussion 438-9. Epub 2006 Jun 2.

Christie Hospital and Salford Royal Hospitals NHS Trusts, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2006.05.017DOI Listing
September 2006

Male adnexal tumour of probable Wolffian duct origin.

Scand J Urol Nephrol 2005 ;39(6):520-2

Department of Urology, Hope Hospital, Manchester, UK.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1080/0036559050020160
Publisher Site
http://dx.doi.org/10.1080/00365590500201602DOI Listing
March 2006

The increased rate of prostate specific antigen testing has not affected prostate cancer presentation in an inner city population in the UK.

BJU Int 2006 Feb;97(2):266-9

Department of Urology, Hope Hospital, Salford Royal Hospitals NHS Trust, Salford, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2005.06011.xDOI Listing
February 2006

Impact of socioeconomic status on bladder cancer outcome.

Curr Opin Urol 2005 Sep;15(5):328-31

Department of Urology, Christie Hospital, Manchester, UK,

View Article

Download full-text PDF

Source
September 2005

Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer.

Int J Radiat Oncol Biol Phys 2005 Feb;61(2):420-5

Department of Urology, Christie Hospital NHS Trust, Manchester M20 4XB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2004.05.074DOI Listing
February 2005

The molecular staging of prostate cancer.

BJU Int 2004 Dec;94(9):1217-20

Genito-Urinary Cancer Research Group, Christie Hospital, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2004.05145.xDOI Listing
December 2004

Differential inhibition of invasion and proliferation by bisphosphonates: anti-metastatic potential of Zoledronic acid in prostate cancer.

Eur Urol 2004 Sep;46(3):389-401; discussion 401-2

Genito-Urinary Cancer Research Group, Kay Kendall Laboratory, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester, M20 4BX, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2004.04.022DOI Listing
September 2004